Ischemia-modified albumin in stable coronary atherosclerotic heart disease: Clinical diagnosis and risk stratification

Coronary Artery Disease

Volumn 23, Issue 8, 2012, Pages 538-541

  Zhong, Yigang ^a   Wang, Ningfu ^a   Xu, Haiying ^a   Hou, Xuwei ^a   Xu, Peng ^a   Zhou, Zhanlin ^a  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

albumin cobalt binding test; coronary artery; correlation; diagnosis; ischemia modified albumin; myocardial ischemia

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; ROC CURVE; SERUM ALBUMIN;

EID: 84869501318     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328358a5e9     Document Type: Article

References (21)

1. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2 +) and Ni(2 +) binding amino-acid residues of the N-terminus of human albumin. Eur J Biochem 2001; 268:42-47.
2. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006; 8:27-31.
3. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005; 172:1685-1690.
4. Bar-Or D, Lau E,Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19:311-315.
5. Beetham R, Monk C, Keating L, Benger JR, Kendall J. Effects of storage at-201C on ischemia-modified albumin results. Ann Clin Biochem 2006; 43:500-502.
6. Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, et al. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007; 25:770-773.
7. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of ischemia modified albumin a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21: 29-34.
8. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006; 152:253-262.
9. Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A, Maisel AS. Biomarkers in acute myocardial injury. Transl Res 2012; 159:252-264.
10. Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 2006; 23:764-768.
11. Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, et al. Utility of admission cardiac troponin and 'ischemia modified albumin' measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006; 23:256-261.
12. Roy D, Kaski JC. High-risk acute coronary syndrome patients and cardiac biomarkers in the emergency department: any role for new biomarkers of myocardial ischaemia? Eur Heart J 2007; 28:2297.
13. Collinson PO, Gaze DC. Ischaemia-modified albumin: clinical utility and pitfalls in measurement. J Clin Pathol 2008; 61:1025-1028.
14. Dominguez-Rodriguez A, Abreu-Gonzalez P. Current role of ischemiamodified albumin in routine clinical practice. Biomarkers 2010; 15: 655-662.
15. Dawie J, Chawla R,Worku Y, Azazh A. Diagnosis of ischemic heart disease using CK-MB, troponin-I and ischemia modified albumin. Ethiop Med J 2011; 49:25-33.
16. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006; 92:113-114.
17. Turedi S, Patan T, Gunduz A, Mentese A, Tekinbas C, Topbas M, et al. Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study. Am J Emerg Med 2009; 27:635-640.
18. Mentese A, Mentese U, Turedi S, Gunduz A, Karahan SC, Topbas M, et al. Effect of deep vein thrombosis on ischaemia-modified albumin levels. Emerg Med J 2008; 25:811-814.
19. Gunduz A, Turedi S, Mentese A, Altunayoqlu V, Turan I, Karahan SC, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008; 26:874-878.
20. Kazanis K, Dalamaga M, Nounopoulos C, Manolis AS, Sakellaris N, Jullien G, et al. Ischemia modified albumin, high-sensitivity C-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta 2009; 408:65-69.
21. Van Belle E, Dallongeville J, Vicaut E, Degrandsart A, Baulac C, Montalescot G, et al. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J 2010; 159:570-576.